Zhang Jinfang

7PUBLICATIONS
13CO-AUTHORS
Molecular targetsPredictive and prognostic markersTraditional Chinese medicine and treatmentsCancer therapy (excl. chemotherapy and radiation therapy)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 08, 2026
Hederagenin Promotes Sorafenib Sensitivity in Hepatocellular Carcinoma Through Suppressing SLC7A11 Expression and Inducing Ferroptosis.

|Nov 15, 2024
LincROR promotes tumor growth of colorectal cancer through the miR-145/WNT2B/WNT10A/Wnt/β-catenin regulatory axis.

Li-Qiang Deng, Shi-Ying Li, Tian Xie

|Apr 18, 2024
Aucubin Promotes Osteogenic Differentiation and Facilitates Bone Formation through the lncRNA-H19 Driven Wnt/β-Catenin Signaling Regulatory Axis.

Yong-Xin Mai, Zhi-Peng Li, Feng-Xiang Pang

|Mar 08, 2024
EIF4A3-negatively driven circular RNA β-catenin (circβ-catenin) promotes colorectal cancer progression via miR-197-3p/CTNND1 regulatory axis.

Li-Qiang Deng, Chuan-Jian Shi, Shu-Ting Zhou

|Feb 14, 2023
LncRNA-NEF suppressed oxaliplatin resistance and epithelial-mesenchymal transition in colorectal cancer through epigenetically inactivating MEK/ERK signaling.

Chuan-Jian Shi, Zhi-He Xue, Wei-Qiang Zeng

|Nov 20, 2020
Ultrasound-guided internal branch of superior laryngeal nerve block on postoperative sore throat: A randomized controlled trial.

Li Zhipeng, He Meiyi, Wang Meirong

Pageof 2

Frequent Collaborators

2 joint publications

Zhi-Peng Li

1 joint publications

Chuan-Jian Shi

1 joint publications

Wei-Ming Fu

1 joint publications

Li-Qiang Deng